The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Corporate Updates Drive Movers As UK Indices Gain

Wed, 22nd Oct 2014 16:12

LONDON (Alliance News) - UK stock indices crept higher throughout trading Wednesday to end modestly higher after a mixed start.

Support came from a doveish set of minutes from the latest Bank of England rate-setting meeting and also from some reasonable US inflation data. With earnings season in full swing in both the UK and US, corporate updates drove a number of stand-out stock movers.

The FTSE 100 closed up 0.4% at 6,399.73, the FTSE 250 up 1.0% at 15,170.06, and the AIM All-Share up 0.6% at 709.30.

Major European markets also made gains, with the French CAC 40 up 0.6%, and the German DAX up 0.6%, while US stocks continued to trade higher at the London close, with the DJIA up 0.2%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.3%.

UK stock indices found a little support, while the pound fell against other major currencies, after the minutes of the Bank of England's October Monetary Policy Committee meeting struck a tone of increased caution over economic slowdown, particularly in Europe, leading investors to expect monetary policy to remain accommodative for some time to come.

"Once again, the news on global activity and inflation had, on balance, been modestly to the downside, particularly in the euro area," the minutes read. "There were increasing indications that the slight slowing in the pace of (UK) expansion towards the end of the year that the Committee had been expecting for some time would indeed occur."

The notes showed the Bank of England rate setters voted 7-2 to keep the UK's base interest rate on hold at 0.5%, in line with expectations. The same two members as in the previous two meetings, Martin Weale and Ian McCafferty, voted for a rate hike. The MPC members voted unanimously to maintain the BoE's stock of purchased assets at GBP375 billion, also in line with expectations.

Further thoughts from Weale might be revealed when he speaks on Cambridge on Wednesday evening at 2000 BST.

The pound fell to a four-day low against the dollar at USD1.6010. It hit an intra-day low against the euro of EUR1.2613, although by the time of the European close, the pound had returned to EUR1.2672, about flat on the day. The euro also remains under pressure amid concerns about the upcoming eurozone bank stress test results.

Spanish news agency Efe reported Wednesday that at least 11 of the 130 eurozone banks have failed the tests. European Central Bank officials responded by saying that the news report was pure speculation at this stage. The test results are due to be released on Sunday.

US consumer price inflation came came in fractionally higher than expected at 1.7% year-on-year in September, unchanged from August. That came as a relief to investors given the environment of slowing growth in other regions and given that the consensus expectation was for an easing to 1.6%.

Within the London equity movers, UK motor insurers were amongst the best performers after a report from the Automobile Association indicated that premiums in the industry are on the rise for the first time in more than two years. The AA said its index tracking the cheapest comprehensive cover available edged up by GBP6, or 1.2%, in the three months to September 30 to GBP531 per annum. For the overall market, premiums were up 4.2% over the same period to an average of GBP891 per annum.

Shore Capital questioned the use of the report as an indicator of things to come, given that the AA said "claims pressure is pushing premiums up". Even so, Admiral closed up 3.3%, Direct Line gained 3.2%, and esure Group rose 6.7%.

Otherwise it was corporate updates that drove London's moving stocks. GlaxoSmithKline was amongst the best blue-chip performers, up 3.2%, after launching a restructuring of its global pharmaceuticals business with the aim of saving about GBP1 billion a year and saying it will return GBP4 billion to shareholders in 2015 on top of its usual dividend payouts. Glaxo posted a pretax profit of GBP548 million for the third quarter of 2014, down from GBP1.40 billion a year before, as revenue fell to GBP5.65 billion from GBP6.51 billion.

British American Tobacco weighed at the other end of the blue chip index, down 2.8%, after saying that its profitability has been hit by the relative strength of the pound. Its nine-month revenue was up 2.4% at constant exchange rates but down 9.6% at actual rates.

Zoopla ended as one of the best FTSE 250 performers, up 7.2%. The property search company received a vote of confidence from Jefferies. The brokerage sees a huge 60% upside to the stock and is unconcerned about the threat posed by soon-to-be launched rival search site Agents Mutual.

Gaming company Playtech gained 5.1% after reporting faster-than-expected revenue growth. Revenue was EUR116.5 million in the three months to end-September, up from EUR90.6 million a year earlier, as casino software sales rose by a third to EUR62.4 million.

International Personal Finance rose 5.0% after the home credit business reported a 5% rise in pretax profit in the third quarter to GBP34.0 million, up from GBP32.5 million a year earlier. Revenue rose to GBP245.5 million from GBP264.4 million, helped by a 4.8% increase in customer numbers to 2.6 million.

Clothing retailer SuperGroup was the worst performer in the FTSE 250, ending down 5.3% after announcing a management reshuffle. The retailer has appointed Non-Executive Director Euan Sutherland as its new chief executive, with founder Julian Dunkerton moving to the newly created role of founder and product and brand director, a move the company said would assist an accelerated expansion overseas. That move has been welcomed by most analysts, but they have also trimmed full-year estimates for the company due to the warm UK weather that has hit the clothing retail sector in general over September and early October.

Aerospace and defence company Senior lost 2.4% after saying that its adjusted pretax profit in the period since July 1 has been in line with its expectations and that it expects its full-year results to meet forecasts. Analysts have sounded a note of caution, however, over uncertainty on the level of additional costs to the business into 2015. Following a strong run in the shares ahead of the update, Numis Securities has downgraded the stock to Add from Buy.

Another busy day of corporate releases Thursday brings the much-anticipated interim results of troubled supermarket chain Tesco, from which investors will be keen to find out what happened to the GBP250 million it said it couldn't account for a few weeks ago.

Full year numbers are are due from Britvic and Debenhams. Third quarter numbers are scheduled from Ladbrokes, Hochschild Mining, Anglo American, Unilever, African Barrick Gold, and Premier Foods.

Preliminary PMI data for October from across the eurozone will be key on Thursday, given the focus on eurozone growth. Domestically, retail sales data will be in focus, while the Chinese HSBC manufacturing PMI released ahead of the market open may provide an early driver.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.